AlphaMaven AlphaMaven

Palliser Capital pushes for break-up of UK defence group Chemring

Reported by Hedgeweek
Nov 19, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • Palliser Capital, the London-based investment firm led by former Elliott Management executive James Smith, has built a stake of approximately 3% in UK defence group Chemring and is calling for a break-up, according to the Financial Times.
  • • Palliser estimates Chemring's electronic warfare and defence engineering subsidiary Roke could be worth between £600m and £730m as a standalone business and is urging a strategic review including a potential sale.
  • • Palliser argues the remaining energetics division, which makes military explosives, missile components and countermeasures, is well placed to benefit from rising European defence spending, describing Chemring as the continent's only independent publicly listed supplier of high-end military explosives.
  • • Palliser claims Chemring has delivered the weakest shareholder returns among peers during the current rearmament cycle, with shares broadly unchanged over the past year against a market capitalisation of approximately £1.4bn.
  • • The campaign coincides with a leadership transition, as CEO Michael Ord retires in January and successor Tom Newman, a former Babcock International executive, joined in October; private equity investor Albion River holds a 14% stake, making it the largest shareholder.
Summary
Palliser Capital is calling for a break-up of UK defence group Chemring, arguing that the company has failed to capitalise on rising European military spending and could unlock significant shareholder value by separating its businesses, according to a report by the Financial Times. The London-based firm, led by former Elliott Management executive James Smith, holds an approximate 3% stake and is urging the board to undertake a strategic review, including a potential sale of Roke, Chemring's electronic warfare and defence engineering subsidiary. Palliser estimates Roke could be worth between £600m and £730m as a standalone business.

The proposed separation would allow Chemring to focus on its energetics division, which manufactures military explosives, missile components and defensive countermeasures. Palliser contends this business is particularly well positioned to benefit from increased defence expenditure across Europe, describing Chemring as the continent's only independent publicly listed supplier of high-end military explosives. Despite higher defence spending following Russia's invasion of Ukraine, Palliser claims Chemring has delivered the weakest shareholder returns among its peers during the current rearmament cycle. The company, with a market capitalisation of approximately £1.4bn, has seen its shares remain broadly unchanged over the past year.

Chemring has nonetheless benefited from strong demand, reporting a record order book of £1.4bn for the financial year ending October. However, delays in contract awards within its UK sensors business contributed to an 8% decline in underlying operating profit to £24.5m in the six months to April. The company earlier this month also announced plans to dispose of its US sensors business.

The activist campaign comes amid a leadership transition. Chief executive Michael Ord is due to retire in January after more than eight years in the role, while his successor, former Babcock International executive Tom Newman, joined the company in October. Private equity investor Albion River has built a 14% stake, making it Chemring's largest shareholder. Palliser has requested a meeting with chair Tony Wood and has previously engaged with management. The hedge fund has a record of UK activism, including Capricorn Energy, where its push for boardroom changes preceded an agreed sale.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Hedgeweek Palliser Capital pushes for break-up of UK defence group Chemring